Your browser doesn't support javascript.
loading
Corrigendum to "Bringing safe and effective therapies to premenopausal women with breast cancer: efforts to broaden eligibility criteria": [Annals of Oncology 32 (2021) 950-953].
Gao, J J; Krol, D; Narayan, P; Cardoso, F; Regan, M M; Goetz, M P; Hurvitz, S A; Mauro, L; Hodgdon, C; Miller, C P; Booth, B; Bloomquist, E; Ison, G; Osgood, C; Bhatnagar, V; Fashoyin-Aje, L; Pazdur, R; Amiri-Kordestani, L; Beaver, J A.
Afiliação
  • Gao JJ; Oncology Center of Excellence. Electronic address: jennifer.gao@fda.hhs.gov.
  • Krol D; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA.
  • Narayan P; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA.
  • Cardoso F; Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation and ABC Global Alliance, Lisbon, Portugal.
  • Regan MM; Division of Biostatistics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.
  • Goetz MP; Department of Oncology and Pharmacology, Mayo Clinic, Rochester, USA.
  • Hurvitz SA; David Geffen School of Medicine, University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, USA.
  • Mauro L; Inova Schar Cancer Institute, Fairfax, USA.
  • Hodgdon C; Patient Advocate, Washington, USA.
  • Miller CP; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA.
  • Booth B; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA.
  • Bloomquist E; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA.
  • Ison G; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA.
  • Osgood C; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA.
  • Bhatnagar V; Oncology Center of Excellence.
  • Fashoyin-Aje L; Oncology Center of Excellence; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA.
  • Pazdur R; Oncology Center of Excellence; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA.
  • Amiri-Kordestani L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA.
  • Beaver JA; Oncology Center of Excellence; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA.
Ann Oncol ; 33(3): 356, 2022 Mar.
Article em En | MEDLINE | ID: mdl-35012799
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article